Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  1997-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.56.12.723PMID 9496151PMCID PMC1752304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis.

  2010cited by this paper
• Epi info, version 6 : a word-processing, database, and statistics program for public health on IBM-compatible microcomputers

  1996cited by this paper
• Classification of systemic sclerosis.

  1994cited by this paper
• Early Undifferentiated Connective Tissue Disease: III. Outcome and Prognostic Indicators in Early Scleroderma (Systemic Sclerosis)

  1993cited by this paper
• The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis.

  1991cited by this paper
• Predictors of survival in systemic sclerosis (scleroderma).

  1991cited by this paper
• Cutaneous and serologic subsets of systemic sclerosis.

  1991cited by this paper
• Scleroderma and survival.

  1991cited by this paper
• Epidemiology and natural history of systemic sclerosis.

  1990cited by this paper
• Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

  1988cited by this paper
• Prognostic importance of cardiac arrhythmias in systemic sclerosis.

  1988cited by this paper
• A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease.

  1988cited by this paper
• Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.

  1986cited by this paper
• Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound.

  1985cited by this paper
• Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features.

  1985cited by this paper
• Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis.

  1984cited by this paper
• Hypertension and Renal Failure (Scleroderma Renal Crisis) in Progressive Systemic Sclerosis: REVIEW OF A 25‐YEAR EXPERIENCE WITH 68 CASES

  1983cited by this paper
• APACHE—acute physiology and chronic health evaluation: a physiologically based classification system

  1981cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis.

  1976cited by this paper
• Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.

  1971cited by this paper
• Survival in scleroderma.

  1971cited by this paper
• Prognostic Significance of Raynaud's Phenomenon and Other Clinical Characteristics of Systemic Scleroderma: A Study of 271 Cases

  1960cited by this paper
• Clinical pulmonary function testing.

  1959cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper
• A Statistical Problem Arising from Retrospective Studies

  1956cited by this paper
• ARTHRITIS AND ALLIED CONDITIONS

  1949cited by this paper

• Gangrenous Digital Ischemia Unmasking HIV Infection in Untreated Systemic Sclerosis

  2025cites this paper
• [Lung transplantation for scleroderma lung disease].

  2023cites this paper
• Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets

  2021cites this paper
• Turkish Thoracic Society Consensus Report: Interpretation of Spirometry.

  2019cites this paper
• Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study.

  2018cites this paper
• Systemic sclerosis: Clinical manifestations, anesthetic and orthopedic considerations in a patient

  2017cites this paper
• Novel risk factors related to cancer in scleroderma.

  2017cites this paper
• Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review.

  2017influential citation
• Survival, Mortality, Causes of Death and Risk Factors of Poor Outcome

  2017cites this paper
• Lung Transplantation in Patients With Systemic Sclerosis

  2017influential citation
• Lung Transplant in Patients with Scleroderma Compared with Pulmonary Fibrosis

  2016cites this paper
• Lung Transplant in Patients with Scleroderma Compared with Pulmonary Fibrosis. Short- and Long-Term Outcomes.

  2016cites this paper
• Anticuerpos antinucleares específicos de la esclerodermia como determinantes del pronóstico y de los diferentes patrones clínicos de la enfermedad

  2016cites this paper
• Registry of the Spanish Network for Systemic Sclerosis

  2015cites this paper
• Mortality and survival in systemic sclerosis: systematic review and meta-analysis.

  2014cites this paper
• Early- versus Late-Onset Systemic Sclerosis

  2014cites this paper
• Incidence of Pulmonary Hypertension in Patients With Systemic Sclerosis and No Pulmonary Symptoms: Is Annual Echocardiographic Screening Necessary?

  2014cites this paper
• Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature.

  2014cites this paper
• Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody.

  2014cites this paper
• Seminars in Arthritis and Rheumatism

  2014cites this paper
• Systemic Sclerosis: Results from a multicenter survey of Norwegian patients

  2014cites this paper
• Cambios en el patrón de mortalidad de la cohorte del registro español de esclerodermia

  2014cites this paper
• Lung transplantation in patients with scleroderma

  2013cites this paper
• Low Socioeconomic Status (Measured by Education) and Outcomes in Systemic Sclerosis: Data from the Canadian Scleroderma Research Group

  2013cites this paper
• Effect of dihydropyridine calcium channel blockers and glucocorticoids on the prevention and development of scleroderma renal crisis in an Italian case series.

  2013cites this paper
• Survival and Causes of Death in an Unselected and Complete Cohort of Norwegian Patients with Systemic Sclerosis

  2013cites this paper
• Survival after lung transplantation in systemic sclerosis. A systematic review.

  2013cites this paper
• Latent pulmonary inflammation in patients with systemic sclerosis.

  2012cites this paper
• The six‐minute walk test in scleroderma: What should we measure and how should we measure it?

  2012cites this paper
• Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.

  2012cites this paper
• Latent Pulmonary Inflammation in Patients With Systemic Sclerosis

  2012cites this paper
• Can we predict the severity of pulmonary hypertension in patients with scleroderma?

  2012cites this paper
• Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies.

  2012cites this paper
• Podemos predecir la gravedad de la hipertensión arterial pulmonar en pacientes con esclerodermia

  2012cites this paper
• Association of C‐reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group

  2012cites this paper
• Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

  2011cites this paper
• Prognostic factors of mortality and 2‐year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand

  2011cites this paper
• Mechanism of coronary flow reserve reduction in systemic sclerosis: insight from intracoronary pressure wire studies.

  2011cites this paper
• Chapter 25 – THE SYSTEMIC SCLERODERMAS AND RELATED DISORDERS

  2011cites this paper
• The prognostic factors of systemic sclerosis for survival among Koreans

  2010cites this paper
• Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.

  2010cites this paper
• Echocardiography as an Outcome Measure in Scleroderma-related Pulmonary Arterial Hypertension: A Systematic Literature Analysis by the EPOSS Group

  2010cites this paper
• Determinants of morbidity and mortality of systemic sclerosis in Canada.

  2010cites this paper
• Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension Results of a systematic literature analysis by the EPOSS group

  2010influential citation
• Association of HLA Class II Genes with Systemic Sclerosis in Spanish Patients

  2009cites this paper
• Spectrum of fibrosing diffuse parenchymal lung disease.

  2009cites this paper
• Systemic sclerosis: A world wide global analysis

  2009cites this paper
• Clinical and genetic factors predictive of mortality in early systemic sclerosis.

  2009cites this paper
• Epidemiologi ved systemisk sklerose (sklerodermi)

  2009cites this paper
• [Raynaud's phenomenon].

  2009cites this paper
• Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation

  2009cites this paper
• Diagnostik und Therapie der Systemsklerose*

  2008cites this paper
• [Systemic sclerosis in men].

  2008cites this paper
• Diagnosis of and Therapy for Systemic Sclerosis

  2008cites this paper
• Induced Sputum in Systemic Sclerosis Interstitial Lung Disease: Comparison to Healthy Controls and Bronchoalveolar Lavage

  2008cites this paper
• Sclérodermie systémique chez l’homme

  2008cites this paper
• Epidemiologi ved systemisk sklerose (sklerodermi) Jan Tore Gran og Øyvind Midtvedt Revmatologisk avdeling, Rikshospitalet-Radiumhospitalet, Oslo

  2008cites this paper
• Classification criteria for systemic sclerosis subsets.

  2007cites this paper
• Interstitial Lung Disease in Systemic Sclerosis

  2007cites this paper
• Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma.

  2006cites this paper
• The Scleroderma Assessment Questionnaire (SAQ)

  2006cites this paper
• The Scleroderma Assessment Questionnaire (SAQ)

  2006cites this paper
• Neuroaxial anesthesia in a patient with progressive systemic sclerosis : case presentation and review of the literature on systemic sclerosis

  2006cites this paper
• The scleroderma Assessment Questionnaire (SAQ). A new self-assessment questionnaire for evaluation of disease status in patients with systemic sclerosis.

  2006cites this paper
• Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases.

  2006cites this paper
• Prevalence of pulmonary hypertension in systemic sclerosis.

  2005cites this paper
• Life-threatening dermatoses due to connective tissue disorders.

  2005cites this paper
• CHAPTER 19 – THE SYSTEMIC SCLERODERMAS AND RELATED DISORDERS

  2005cites this paper
• [Scleroderma].

  2004cites this paper
• Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

  2004cites this paper
• Assessment of lung involvement.

  2003cites this paper
• Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis.

  2003cites this paper
• Mortality and prognostic factors in Spanish patients with systemic sclerosis.

  2003influential citation
• Hematopoietic Stem Cell Transplantation of Autoimmune Disease

  2002cites this paper
• Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I–II study

  2002influential citation
• Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.

  2002cites this paper
• Localized and systemic scleroderma.

  2001cites this paper
• Esophageal involvement and pulmonary manifestations in systemic sclerosis.

  2001cites this paper
• Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale

  2001cites this paper
• Pros and cons of hematopoietic stem cell transplant for autoimmune disease

  2000cites this paper
• Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele

  2000cites this paper
• Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey.

  2000cites this paper
• Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: evidence of free radical-mediated injury.

  2000cites this paper
• Bone marrow transplantation in the treatment of systemic sclerosis

  2000cites this paper
• Esclerose sistêmica difusa com hipertensão pulmonar isolada: relato de caso

  2000cites this paper
• Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit.

  1999cites this paper
• Atteinte pulmonaire au cours de la sclérodermie systémique. Partie I. Pneumopathie interstitielle chronique fibrosante

  1999cites this paper
• Influence de l'âge sur les caractéristiques cliniques et biologiques de la sclérodermie systémique

  1999cites this paper
• [Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease].

  1999cites this paper
• [Influence of age on the clinical and biological characteristics of systemic scleroderma].

  1999cites this paper
• Quantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseases

  1999cites this paper